Hematology

Clinical pharmacy services in hematology can have a significant impact, and the Skidki-na-vse® Hematology resource center provides clinical news and articles about the topic. Here, visitors will find information about upcoming hematology conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
Cancer Drug Costs May Not Be Factored Into Reimbursement
Study finds health-related quality of life is often not collected for novel cancer drugs when they are submitted for reimbursement.
Report Discovers Mechanism for Two Mutations Linked to AML
Two cell mutations have been linked to acute myeloid leukemia, but the reason for their cooperation has been unknown.
Study Reveals Key Role in Cancer Cell Proliferation in Acute Myeloid Leukemia
Study shows the importance of a cancer-causing oncogene, known as SET/TAF1, in triggering cancer cell proliferation.
FDA Approves Combination Treatment for Frontline Multiple Myeloma
Daratumumab was approved based on results from part one of the Phase III CASSIOPEIA study.
Radiation Therapy: Fewer Adverse Events of CAR T-Cell Therapy in Non-Hodgkin Lymphoma
Study indicated that patients who received radiation 30 days or fewer before their CAR T-cell infusion did not experience serious cytokine release syndrome or neurotoxicity.
Diabetes Associated with Increased Risk of Non-Hodgkin Lymphoma
Patients with diabetes demonstrated a higher likelihood of developing non-Hodgkin lymphoma than those without diabetes, especially among men.
 
Trending News Today: Acute Myeloid Leukemia Drug Improves Overall Survival
Top news of the day from across the health care landscape.
The Oncology Pharmacist's Blind Spot
Hematology and oncology pharmacists discussed patient outreach at a panel during the Hematology/Oncology Pharmacy Association’s (HOPA) annual conference in April.
New Approach May Overcome Drug Resistance in Acute Myeloid Leukemia
A new study identified pathways that may serve as therapeutic targets for overcoming drug resistance in acute myeloid leukemia. 
Combating Advancing Cancers With CAR T-Cell Therapy
Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
DAURISMO for Acute Myeloid Leukemia
On November 2018, the FDA approved Pfizer’s glasdegib (Daurismo) for the treatment of newly diagnosed acute myeloid leukemia (AML) in patients 75 years and older with comorbidities that prevent the use of intensive induction-dose chemotherapy.
Melanoma Associated with CLL Creates Need for Closer Monitoring
The study findings suggest that, while the link between chronic lymphocytic leukemia and melanoma had been known, the rate at which the link occurs is higher than expected.
+ Load More